Cloned Receptor Paves Way For New Breast And Prostate Cancer Treatment
 

Researchers at Uppsala University have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells. The study was published last week in PNAS...

More...